Novo Nordisk is gearing up to submit its rare blood disorder drug to the FDA after the former Forma Therapeutics asset ...

Shares of Agios Pharmaceuticals took a header Monday after Novo Nordisk's rival sickle cell treatment succeeded in Phase 3 testing.

Novo Nordisk’s etavopivat elicited a 27% drop in vaso-occlusive crises and 48.7% hemoglobin response after 24 weeks, creating ...

Three years ago, Eli Lilly ( LLY 2.40%) and Novo Nordisk ( NVO +1.87%) had about the same market value. Given how well both ...

Hims & Hers Health (NYSE:HIMS) shares are up 9% in early trading Monday, climbing from $28.82 to $31 and change as investors ...

Novo Nordisk will be happy with the results after Pfizer has dropped two SCD assets in recent years. Credit: JHVEPhoto / ...

The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.

Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology ...

Novo Nordisk (NVO) stock is in focus as the company expands its workforce by ~2,000 YTD after major layoffs and restructuring ...

Novo Nordisk has hired about 2,000 employees this year as it reshapes its workforce following last year’s record layoffs of ...

Etavopivat showed a 27% reduction in vaso-occlusive crisis events and ~4-month delay to first vaso-occlusive crisis event on ...